|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0008838,
umls-concept:C0014582,
umls-concept:C0016360,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0040808,
umls-concept:C0205177,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C0444889,
umls-concept:C1517927,
umls-concept:C1522484
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1994-7-1
|
|
pubmed:abstractText |
To investigate the efficacy and toxicity of continuous infusion fluorouracil (5-FU) with every-3-weeks epirubicin and cisplatin (ECF) in advanced breast cancer in a phase II study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1259-65
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8201387-Adult,
pubmed-meshheading:8201387-Aged,
pubmed-meshheading:8201387-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8201387-Breast Neoplasms,
pubmed-meshheading:8201387-Cisplatin,
pubmed-meshheading:8201387-Epirubicin,
pubmed-meshheading:8201387-Female,
pubmed-meshheading:8201387-Fluorouracil,
pubmed-meshheading:8201387-Humans,
pubmed-meshheading:8201387-Infusions, Intravenous,
pubmed-meshheading:8201387-Middle Aged,
pubmed-meshheading:8201387-Neoplasm Metastasis
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.
|
|
pubmed:affiliation |
Department of Medicine, Royal Marsden Hospital, London, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
